arrow
W

Willem Pieter Brouwer

Erasmus MC
H指数:25
被引数:2,360

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Senolytics dasatinib and quercetin in metabolic dysfunction-associated steatohepatitis: a proof-of-principle randomized, controlled trial

代谢功能障碍相关脂肪性肝炎中的 senolytics 达沙替尼和槲皮素:一项概念验证随机对照试验

2026-10-010
OAAI
Comparative performance of HCC risk scores in identifying low-risk patients with cirrhosis: A multicenter cohort study

比较肝硬化患者低风险人群识别中HCC风险评分的性能:一项多中心队列研究

2026-09-020
OAAI
Two-step care pathways for advanced MASLD in primary and hospital care: A multicenter study

针对初级保健和医院护理中晚期MASLD的两步护理路径:一项多中心研究

2026-07-010
PRE
Diagnostic innovation and models of care to improve fibrosis detection and risk stratification in steatotic liver disease

脂肪性肝病的纤维化诊断创新和护理模式以改善纤维化检测和风险分层

2026-05-250
OAAI
Steatotic liver disease trajectory: A holistic EASL guidance on the multidisciplinary approach to screening and patient management☆

脂肪肝疾病进展轨迹:EASL关于多学科方法进行筛查和患者管理的整体性指南☆

2026-02-250
OAAI
Corrigendum to ‘Steatotic liver disease trajectory: A holistic EASL guidance on the multidisciplinary approach to screening and patient management’ [JHEP Reports (2026) 8; 101798; https://doi.org/10.1016/j.jhepr.2026.101798]

更正:‘脂肪肝疾病轨迹:关于多学科方法进行筛查和患者管理的EASL整体指南’ [JHEP Reports (2026) 8; 101798; https://doi.org/10.1016/j.jhepr.2026.101798]

2026-01-010
OA
Diabetes Mellitus is a Risk Factor for Hepatic Encephalopathy Following Transjugular Intrahepatic Portosystemic Shunt

糖尿病是经颈静脉肝内门体分流术后肝性脑病的危险因素。

2025-11-010
PRE
Prediction of Hepatocellular Carcinoma and Other Liver-Related Events in Chronic Hepatitis B Patients With Metabolic Dysfunction or Metabolic Dysfunction-Associated Steatotic Liver Disease

代谢功能障碍或有代谢功能障碍相关脂肪性肝病的慢性乙型肝炎患者中,肝细胞癌及其他肝脏相关事件的预测

2025-09-090
OAAI
Assessing the effects of naltrexone-bupropion on hepatic steatosis and fibrosis in patients with T2DM and overweight or obesity: Insights from a placebo-controlled trial

评估纳曲酮-安非他酮对2型糖尿病合并超重或肥胖患者肝脂肪变性和肝纤维化的影响:来自一项安慰剂对照试验的见解

2025-09-020
OAAI
Association of Metabolic Comorbidities With Fibrosis Severity and Fibrosis Regression in Patients With Chronic Hepatitis B

慢性乙型肝炎患者代谢合并症与肝纤维化严重程度及肝纤维化消退的关系。Clin. Gastroenterol. Hepatol, S1542-3565(25)00411-2

2025-05-150
OAAI
The Association Between Metabolic Dysfunction-Associated Steatotic Liver Disease and Change in Liver Stiffness in Patients With Chronic Hepatitis B

慢性乙型肝炎患者代谢功能障碍相关的脂肪变性肝病与肝脏硬度变化的关系

2025-02-250
OAAI